Lupin Limited – 09/16/2025. Country: India. Record Type: 483
Similar Posts
Division of Oncology 2 (DO2)
The Division of Oncology 2 (DO2) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for the following therapeutic areas: gastrointestinal, lung, and head and neck cancers; neuro-oncology, rare cancers, pediatricJanssen Vaccines Corp., A Johnson & Johnson Company – 713194 – 07/18/2025
CGMP/Finished Pharmaceuticals/AdulteratedHealth and Natural Beauty USA Corp. – 700187 – 07/28/2025
CGMP/Finished Pharmaceuticals/AdulteratedEco Lips, Inc. – 631629 – 08/22/2024
CGMP/Finished Pharmaceuticals/AdulteratedCovalent Medical – 695839 – 07/09/2025
Unapproved New Drugs/MisbrandedHandelnine Global, LLC dba Navafresh – 716013 – 11/17/2025
Unapproved New Drugs/Adulterated/Misbranded